Immudex ApS

Immudex was created in 2009 when it spun off from the diagnostic company Dako, now Agilent. Since then, Immudex has grown in numbers, employees, patents, product lines, partnerships, and customers served. Research, development, and commercial activities are headquartered in Copenhagen, Denmark, with operations in North America since 2010 out of Fairfax, Virginia. The foundation of Immudex is not a product. Instead, it is the certainty that a detailed understanding of the immune system can expand medicine boundaries and open new therapeutic and diagnostic opportunities. The immune system and its cellular response are highly complex, and with the right research and diagnostic tools, we can unravel that complexity. At the core of our vision is the desire to be there for researchers and clinicians worldwide, helping them develop more effective immune-based therapeutics and diagnostics.